Myriad Genetics | MYGN - Actif À Court Terme

Prix De L'Action
4.35
Variation Quotidienne
-0.09 -2.03%
Mensuellement
-14.03%
Annuel
-45.63%
Q2 Prévisions
4.61




Actif À Court Terme Changement Date
Agilent USD 4.62B 21M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Danaher USD 12.76B 3.15B 2025-12
Hologic USD 3.84B 175.3M 2025-12
Illumina USD 3.29B 493M 2025-12
J&J USD 55.62B 1.01B 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Quest Diagnostics USD 2.38B 29M 2025-12
Quidel USD 1.45B 80.6M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Standard Biotools USD 454.26M 18.18M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Veracyte USD 488.38M 39.15M 2025-12
Waters USD 1.99B 69.86M 2025-12